BPC-157, short for Body Protective Compound 157, is a synthetic pentadecapeptide derived from a naturally occurring protein fragment found in human gastric juice
They work through fundamentally different mechanisms, which is why they're often combined
Patients treated with semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) approved for treating type 2 diabetes (T2D) and for weight management have reported reduced desire to drink and smoke
These options may include phone support, email assistance, live chat, and online help centres
Powell-Wiley TM, Poirier P, Burke LE, Desprs JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, et al